Skip to main content
. Author manuscript; available in PMC: 2020 Aug 1.
Published in final edited form as: J Mol Endocrinol. 2019 Aug 1;63(2):123–138. doi: 10.1530/JME-19-0021

Figure 9. 4EGI-1 treatments can upregulate the expression of proteins associated with the m6A pathway in mouse liver.

Figure 9.

A) Representative western blot analysis of 4EGI-1 treatments in liver. B) Bar graph with the mean ± S.E.M. from at least four control mice and nine 4EGI-1 treated mice per group. All values were normalized to the respective controls. The (*) indicates statistical significance (p<0.05) relative to controls. C) CT values of qRT-PCR performed in mRNA purified from samples shown in panel B.